NO20031615L - Pyrazol-derivater for behandling av virus-sykdommer - Google Patents

Pyrazol-derivater for behandling av virus-sykdommer

Info

Publication number: NO20031615L
Authority: NO; Norway
Prior art keywords: treatment; viral diseases; pyrazole derivatives; pyrazole; derivatives
Prior art date: 2000-10-10

Application number

NO20031615A

Other languages

English (en)

Norwegian (no)

Other versions

NO20031615D0 (no

Inventor

Bryan William Dymock

Philip Stephen Jones

John Herbert Merrett

Martin John Parratt

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-10

Filing date

2003-04-09

Publication date

2003-05-23

2003-04-09 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2003-04-09 Publication of NO20031615D0 publication Critical patent/NO20031615D0/no

2003-05-23 Publication of NO20031615L publication Critical patent/NO20031615L/no

Links

201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
150000003217 pyrazoles Chemical class 0.000 title 1
230000003612 virological effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20031615A 2000-10-10 2003-04-09 Pyrazol-derivater for behandling av virus-sykdommer NO20031615L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0024795.7A GB0024795D0 (en)	2000-10-10	2000-10-10	Pyrazole derivatives for the treatment of viral diseases
PCT/EP2001/011474 WO2002030907A1 (en)	2000-10-10	2001-10-04	Pyrazole derivatives for the treatment of viral diseases

Publications (2)

Publication Number	Publication Date
NO20031615D0 NO20031615D0 (no)	2003-04-09
NO20031615L true NO20031615L (no)	2003-05-23

Family

ID=9900999

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031615A NO20031615L (no)	2000-10-10	2003-04-09	Pyrazol-derivater for behandling av virus-sykdommer

Country Status (28)

Country	Link
US (2)	US6699887B2 (cs)
EP (1)	EP1326843A1 (cs)
JP (1)	JP4015548B2 (cs)
KR (1)	KR100534158B1 (cs)
CN (2)	CN1191239C (cs)
AR (1)	AR030858A1 (cs)
AU (2)	AU2002221651B2 (cs)
BR (1)	BR0114483A (cs)
CA (1)	CA2423515A1 (cs)
CZ (1)	CZ20031297A3 (cs)
EC (1)	ECSP034547A (cs)
GB (1)	GB0024795D0 (cs)
GT (1)	GT200100201A (cs)
HR (1)	HRP20030251A2 (cs)
HU (1)	HUP0302722A2 (cs)
IL (1)	IL154875A0 (cs)
MA (1)	MA26951A1 (cs)
MX (1)	MXPA03003070A (cs)
NO (1)	NO20031615L (cs)
NZ (1)	NZ524740A (cs)
PA (1)	PA8530301A1 (cs)
PE (1)	PE20020750A1 (cs)
PL (1)	PL362918A1 (cs)
RU (1)	RU2270832C2 (cs)
UY (1)	UY26956A1 (cs)
WO (1)	WO2002030907A1 (cs)
YU (1)	YU27203A (cs)
ZA (1)	ZA200302519B (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE430567T1 (de) *	2000-09-29	2009-05-15	Topotarget Uk Ltd	Carbaminsäurederivate enthaltend eine amidgruppe zur behandlung von malaria
GB0113524D0 (en) *	2001-06-04	2001-07-25	Hoffmann La Roche	Pyrazole derivatives
MXPA05003195A (es) *	2002-09-26	2005-06-08	Pfizer	Derivados de pirazol como inhibidores de la transcriptasa inversa.
US7230025B2 (en)	2002-09-26	2007-06-12	Pfizer, Inc.	Pyrazole derivatives
JP2006505625A (ja)	2002-09-26	2006-02-16	ファイザー・インク	Ｈｉｖ感染症を治療するためのピラゾールアミド
GB0223234D0 (en) *	2002-10-07	2002-11-13	Pfizer Ltd	Chemical compounds
GB0223232D0 (en) *	2002-10-07	2002-11-13	Pfizer Ltd	Chemical compounds
US6933312B2 (en)	2002-10-07	2005-08-23	Agouron Pharmaceuticals, Inc.	Pyrazole derivatives
TW200423930A (en) *	2003-02-18	2004-11-16	Hoffmann La Roche	Non-nucleoside reverse transcriptase inhibitors
BRPI0408704A (pt)	2003-03-24	2006-03-07	Hoffmann La Roche	benzil-piridazinonas como inibidores de transcriptase reversa
US7220772B2 (en)	2003-09-05	2007-05-22	Pfizer, Inc.	Pyrazole derivatives
WO2006004040A1 (ja) *	2004-07-01	2006-01-12	Daiichi Asubio Pharma Co., Ltd.	Ｐｄｅ７阻害作用を有するチエノピラゾール誘導体
US20070005049A1 (en) *	2005-06-30	2007-01-04	Comben Richard H	Apparatus and Method of Treating Urinary Incontinence by Heating Urethra
EP2046774A1 (en) *	2006-07-05	2009-04-15	Pfizer Products Inc.	Pyrazole derivatives as cytochrome p450 inhibitors
BRPI0715193A2 (pt)	2006-08-16	2013-10-01	Hoffmann La Roche	inibidores nço-nucleosÍdicos da transcriptase reversa
GB0713479D0 (en) *	2007-07-11	2007-08-22	Syngenta Participations Ag	Substituted aromatic heterocyclic compounds as fungicides
CN101903382B (zh)	2007-12-21	2012-11-28	弗·哈夫曼-拉罗切有限公司	杂环抗病毒化合物
GB0823000D0 (en) *	2008-12-17	2009-01-28	Syngenta Participations Ag	Isothiazole and pyrazole derivatives with plant growth regulating properties
SG173829A1 (en)	2009-02-25	2011-09-29	Daiichi Sankyo Co Ltd	Tricyclic pyrazolopyrimidine deritives
FR2951549B1 (fr)	2009-10-15	2013-08-23	Olivier Schussler	Procede d'obtention de bioprotheses medicales implantables
CA2809120C (en)	2010-08-23	2015-10-13	Daiichi Sankyo Company, Limited	Crystal of tricyclic pyrazolopyrimidine derivative
BR112013004258A2 (pt)	2010-08-23	2016-08-02	Daiichi Sankyo Co Ltd	cristal, composição farmacêutica, e, agente anticâncer
US9695127B2 (en)	2012-11-08	2017-07-04	University of Pittsburgh—of the Commonwealth System of Higher Education	Compounds for treating HIV and methods for using the compounds
US9925190B2 (en)	2015-02-16	2018-03-27	University of Pittsburgh—of the Commonwealth System of Higher Education	Small molecules targeting HIV-1 Nef
EP3778583B1 (en)	2018-03-30	2025-06-18	Sumitomo Chemical Company, Limited	Heterocyclic compound and arthropod pest control composition containing same
WO2020081856A1 (en) *	2018-10-18	2020-04-23	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Inhibitors of hiv-1 nef for the treatment of hiv disease
FR3121927B1 (fr)	2021-04-19	2023-03-31	Eiffage Genie Civil Terrassement	Procédé d’inertage des boues d’excavation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993015060A1 (fr)	1992-01-22	1993-08-05	Nissan Chemical Industries, Ltd.	Derive de pyrazole substitue et bactericide agrohorticole
AU690527B2 (en) *	1992-12-17	1998-04-30	Pfizer Inc.	Pyrazoles having CRF antagonist activity
TW336932B (en) *	1992-12-17	1998-07-21	Pfizer	Amino-substituted pyrazoles
EP0959074A3 (en) *	1992-12-17	2000-06-07	Pfizer Inc.	Substituted pyrazoles as CRF antagonists
US6005109A (en)	1997-10-30	1999-12-21	Pflizer Inc.	Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
WO2006027423A1 (fr) *	2004-08-09	2006-03-16	Simag Developpement	Dispositif de saisie comportant un capteur optique suivi d’un moyen de filtrage

2000
- 2000-10-10 GB GBGB0024795.7A patent/GB0024795D0/en not_active Ceased
2001
- 2001-09-20 US US09/956,656 patent/US6699887B2/en not_active Expired - Fee Related
- 2001-10-04 MX MXPA03003070A patent/MXPA03003070A/es active IP Right Grant
- 2001-10-04 YU YU27203A patent/YU27203A/sh unknown
- 2001-10-04 RU RU2003112610/04A patent/RU2270832C2/ru not_active IP Right Cessation
- 2001-10-04 PL PL01362918A patent/PL362918A1/xx not_active Application Discontinuation
- 2001-10-04 HU HU0302722A patent/HUP0302722A2/hu unknown
- 2001-10-04 JP JP2002534293A patent/JP4015548B2/ja not_active Expired - Fee Related
- 2001-10-04 CZ CZ20031297A patent/CZ20031297A3/cs unknown
- 2001-10-04 EP EP01986680A patent/EP1326843A1/en not_active Withdrawn
- 2001-10-04 NZ NZ524740A patent/NZ524740A/en unknown
- 2001-10-04 WO PCT/EP2001/011474 patent/WO2002030907A1/en not_active Ceased
- 2001-10-04 CN CNB018171710A patent/CN1191239C/zh not_active Expired - Fee Related
- 2001-10-04 AU AU2002221651A patent/AU2002221651B2/en not_active Ceased
- 2001-10-04 IL IL15487501A patent/IL154875A0/xx unknown
- 2001-10-04 BR BR0114483-9A patent/BR0114483A/pt not_active Application Discontinuation
- 2001-10-04 KR KR10-2003-7004984A patent/KR100534158B1/ko not_active Expired - Fee Related
- 2001-10-04 CA CA002423515A patent/CA2423515A1/en not_active Abandoned
- 2001-10-04 CN CNA2005100088329A patent/CN1680333A/zh active Pending
- 2001-10-04 AU AU2165102A patent/AU2165102A/xx active Pending
- 2001-10-04 HR HR20030251A patent/HRP20030251A2/hr not_active Application Discontinuation
- 2001-10-05 PE PE2001000993A patent/PE20020750A1/es not_active Application Discontinuation
- 2001-10-05 AR ARP010104697A patent/AR030858A1/es not_active Application Discontinuation
- 2001-10-09 GT GT200100201A patent/GT200100201A/es unknown
- 2001-10-09 UY UY26956A patent/UY26956A1/es not_active Application Discontinuation
- 2001-10-09 PA PA20018530301A patent/PA8530301A1/es unknown
2003
- 2003-03-31 ZA ZA200302519A patent/ZA200302519B/en unknown
- 2003-04-07 MA MA27096A patent/MA26951A1/fr unknown
- 2003-04-08 EC EC2003004547A patent/ECSP034547A/es unknown
- 2003-04-09 NO NO20031615A patent/NO20031615L/no unknown
2004
- 2004-01-27 US US10/766,712 patent/US7183296B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN1469865A (zh)	2004-01-21
CA2423515A1 (en)	2002-04-18
RU2003112610A (ru)	2005-02-20
US7183296B2 (en)	2007-02-27
PA8530301A1 (es)	2002-07-30
CN1680333A (zh)	2005-10-12
PE20020750A1 (es)	2002-08-21
US20040192752A1 (en)	2004-09-30
CN1191239C (zh)	2005-03-02
HUP0302722A2 (hu)	2003-12-29
MA26951A1 (fr)	2004-12-20
NO20031615D0 (no)	2003-04-09
AR030858A1 (es)	2003-09-03
US6699887B2 (en)	2004-03-02
ECSP034547A (es)	2003-05-26
KR100534158B1 (ko)	2005-12-06
NZ524740A (en)	2005-09-30
UY26956A1 (es)	2002-04-26
HK1061021A1 (en)	2004-09-03
KR20030046492A (ko)	2003-06-12
BR0114483A (pt)	2003-07-01
IL154875A0 (en)	2003-10-31
AU2165102A (en)	2002-04-22
RU2270832C2 (ru)	2006-02-27
GB0024795D0 (en)	2000-11-22
WO2002030907A1 (en)	2002-04-18
JP2004511469A (ja)	2004-04-15
JP4015548B2 (ja)	2007-11-28
CZ20031297A3 (cs)	2004-01-14
EP1326843A1 (en)	2003-07-16
YU27203A (sh)	2006-05-25
HRP20030251A2 (en)	2005-02-28
MXPA03003070A (es)	2003-07-14
AU2002221651B2 (en)	2006-10-19
US20030018197A1 (en)	2003-01-23
GT200100201A (es)	2002-05-23
ZA200302519B (en)	2004-06-30
PL362918A1 (en)	2004-11-02

Publication	Publication Date	Title
NO20031615D0 (no)	2003-04-09	Pyrazol-derivater for behandling av virus-sykdommer
NO20034523L (no)	2003-12-09	Pyrazolderivater for behandling av HIV
NO20031442L (no)	2003-05-26	Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
DE60124302D1 (de)	2006-12-14	Thiazolderivate zur behandlung von ppar-lierte krankheiten
NO20014379D0 (no)	2001-09-10	Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20033594D0 (no)	2003-08-13	Fenetanolamin-derivater for behandling av luftveissykdommer
NO20031443L (no)	2003-05-26	Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20030012L (no)	2003-03-03	Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20024775D0 (no)	2002-10-03	Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20024777L (no)	2002-12-03	Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024776L (no)	2002-12-03	Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
NO20042640L (no)	2004-06-23	Fremgangsmate for fremstilling av ekinocandinderivater
NO20035538D0 (no)	2003-12-11	Fremgangsmåte for fremstilling av zaleplon
NO20030515L (no)	2003-03-31	Fremgangsmåte for fremstilling av dinapsolin
DK1468996T3 (da)	2008-01-07	Indolderivater til behandling af CNS-sygdomme
NO20032769L (no)	2003-08-18	Kombinasjonsmetode for behandling av virale infeksjoner
NO20012612L (no)	2001-07-17	Isonipecotamider for behandlingen av integrin-formidlede sykdommer
DE60114448D1 (de)	2005-12-01	Imidazolonderivate zur behandlung viraler krankheiten
NO20033290D0 (no)	2003-07-21	Pyrrolderivater for behandling av cytokinformidlede sykdommer
NO20023702D0 (no)	2002-08-06	Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20042166L (no)	2004-05-25	Kombinasjonsterapi for behandling av sykdom
HK1057753A (en)	2004-04-16	Morpholin-acetamide derivatives for the treatment of inflammatory diseases